ZNTL 1.49 ▼ -1.97% Live Trading Data - Stocknear

Zentalis Pharmaceuticals ...

NASDAQ: ZNTL · Real-Time Price · USD
1.49
-0.03 (-1.97%)
At close: Sep 25, 2025, 3:59 PM
1.49
0.00%
After-hours: Sep 25, 2025, 04:10 PM EDT
-1.97%
Bid 1.46
Market Cap 107.48M
Revenue (ttm) 26.86M
Net Income (ttm) -162.78M
EPS (ttm) -2.28
PE Ratio (ttm) -0.65
Forward PE -0.72
Analyst Hold
Dividends n/a
Ask 1.59
Volume 517,811
Avg. Volume (20D) 904,242
Open 1.51
Previous Close 1.52
Day's Range 1.49 - 1.56
52-Week Range 1.01 - 4.44
Beta 1.77
Ex-Dividend Date n/a

About ZNTL

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ZNTL
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for ZNTL stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
7 months ago
-21.25%
Zentalis Pharmaceuticals shares are trading lower.... Unlock content with Pro Subscription
8 months ago
-1.08%
Zentalis Pharmaceuticals shares are trading higher after the company announced that the FDA has granted Fast Track Designation to azenosertib for the treatment of patients with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer.